Status:

TERMINATED

Salvage Cryotherapy in Recurrent Prostate Cancer

Lead Sponsor:

University of Colorado, Denver

Collaborating Sponsors:

Boston Scientific Corporation

Conditions:

Recurrent Prostate Cancer

Eligibility:

MALE

30-80 years

Brief Summary

To provide a systemic, uniform and user-friendly tool for collection of data on prostate cancer salvage cryotherapy in a multicenter setting. The goal is to learn more about the short and long term ef...

Eligibility Criteria

Inclusion

  • Read \& understand informed consent related to this study including consenting and HIPPA authorization
  • Undergone salvage cryotherapy of the prostate for recurrent prostate cancer

Exclusion

  • Patients who underwent radical prostatectomy as their primary therapy or other significant surgery (except prostatic biopsy)
  • Patients with clinically confirmed distant metastasis (unless deemed beneficial by the treating physician)
  • Any previous major rectal surgery
  • Clinically significant lower urinary tract or rectal anomalies
  • Existing urethral, rectal, or bladder fistulae

Key Trial Info

Start Date :

January 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00824928

Start Date

January 1 2007

End Date

December 1 2012

Last Update

May 27 2015

Active Locations (17)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (17 locations)

1

Loma Linda University

Loma Linda, California, United States, 92354

2

Kaiser Permanente

Sacremento, California, United States, 95825

3

Prostate Institute of America

Ventura, California, United States, 93003

4

University of Colorado at Denver and Health Sciences Center

Aurora, Colorado, United States, 80045